Christian Antoine Lucien Ribeyrolle - Mar 1, 2023 Form 4 Insider Report for RAYONIER ADVANCED MATERIALS INC. (RYAM)

Role
Vice President, Biomaterials
Signature
Brenda K. Davis, Attorney-in-Fact
Stock symbol
RYAM
Transactions as of
Mar 1, 2023
Transactions value $
$0
Form type
4
Date filed
3/3/2023, 04:02 PM
Previous filing
Mar 3, 2022
Next filing
Mar 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RYAM Common Stock Award $0 +4.81K +122.42% $0.00 8.73K Mar 1, 2023 Direct F1
transaction RYAM Common Stock Options Exercise $0 +3.33K +38.19% $0.00 12.1K Mar 1, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RYAM Restricted Stock Units Award $0 +8.94K $0.00 8.94K Mar 1, 2023 Common Stock 8.94K Direct F2
transaction RYAM Restricted Stock Units Options Exercise $0 -3.33K -100% $0.00* 0 Mar 1, 2023 Common Stock 3.33K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Paid pursuant to 2020 Performance Share Unit Award Agreement.
F2 Each restricted stock unit represents a contingent right to receive one share of RYAM common stock.
F3 Due to an administrative error the exercisable date and the expiration date were incorrectly reported as March 2, 2023 instead of March 1, 2023.